metaCARpal Bone Osteosynthesis Trail
CARBO
The CARBO Study (metaCARpal Bone Osteosynthesis)
2 other identifiers
interventional
552
1 country
1
Brief Summary
Background Metacarpal shaft fractures account for 30-50% of hand fractures (Karl et al., 2015; Kollitz et al., 2014; van Onselen et al., 2003), with diaphyseal spiral and oblique fractures of the second to fifth ray posing unique challenges due to the risks of shortening and rotational deformities. Current standard care of displaced fractures involves operative fixation. However, retrospective studies have indicated that nonoperative treatment, involving early mobilization or buddy taping, can achieve outcomes comparable to operative treatment (Daher et al., 2023). There is only one published, with a small sample size, randomized controlled trial (RCT) investigating this issue (Peyronson et al., 2023). This highlights the need for a robust multicenter RCT to address these gaps in evidence. Aim The aim of this study is to compare the one-year outcomes of non-operative treatment involving immediate unrestricted mobilization versus operative treatment of displaced oblique or spiral diaphyseal metacarpal fractures in adults. Materials and Methods This is a multicenter, pragmatic, prospective, noninferiority RCT involving 552 adult patients with displaced oblique and/or spiral diaphyseal metacarpal fractures of the second to fifth ray. Participants will be randomized 1:1 to receive either nonoperative treatment with unrestricted mobilization and rehabilitation) or operative treatment (with screw or plate fixation) followed by rehabilitation. The primary outcome is grip-strength in the injured hand presented in kilograms at one year. Secondary outcomes include questionnaires, complications, range of motion, patient reported outcome measures, health related quality of life, patient satisfaction, and radiographic healing. A power calculation proposes a study size of 552 participants to detect a noninferiority margin of 10% in grip strength.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2025
CompletedFirst Posted
Study publicly available on registry
January 22, 2026
CompletedStudy Start
First participant enrolled
March 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 15, 2031
March 24, 2026
March 1, 2026
4 years
December 15, 2025
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Grip strength
The primary outcome is grip-strength measured in the injured hand using a JAMAR dynamometer at 12 months and presented in kilograms. Measurement method will follow the technical description presented in the HAKIR manual (HAKIR, 2023).
From enrollment to the end of follow-up at 12 months
Secondary Outcomes (12)
Complications
From enrollment to the end of follow-up at 12 months
Pain in injured hand NRS
From enrollment to the end of follow-up at 12 months
Rotational deformity
12 months
PROM - patient rated outcome measure
6, 12 weeks, 12 months
Range of motion
6, 12 weeks, 12 months
- +7 more secondary outcomes
Study Arms (2)
Non-operative with early mobilization
EXPERIMENTALParticipants randomized to the nonoperative group will receive immediate unrestricted mobilization, with optional buddy taping or removable splinting for comfort. Closed reduction will not be attempted. Rehabilitation protocol with early mobilization will be standardized across study centers with printed standardized information to patients and rehabilitation staff.
Operative
ACTIVE COMPARATORParticipants randomized to the operative group will undergo open reduction and internal fixation (ORIF) of the MSF. Peri-operative antibiotic prophylaxis will be administered according to local guidelines. The surgical approach and fixation method (e.g. compression screws and/or plate, not K-wires) will be at the discretion of the treating surgeon, following standard surgical principles. Postoperative immobilisation will adhere to surgeons' preference but not exceed two weeks fixation.
Interventions
Participants randomized to the nonoperative group will receive immediate unrestricted mobilization, with optional buddy taping or removable splinting for comfort. Closed reduction will not be attempted. Rehabilitation protocol with early mobilization will be standardized across study centers with printed standardized information to patients and rehabilitation staff.
Participants randomized to the operative group will undergo open reduction and internal fixation (ORIF) of the MSF. Peri-operative antibiotic prophylaxis will be administered according to local guidelines. The surgical approach and fixation method (e.g. compression screws and/or plate, not K-wires) will be at the discretion of the treating surgeon, following standard surgical principles. Postoperative immobilisation will adhere to surgeons' preference but not exceed two weeks fixation.
Eligibility Criteria
You may qualify if:
- Age ≥18 years.
- Access to a valid e-mail.
- Normal bilateral hand function prior to injury.
- Ability and willingness to provide written informed consent
- Single, displaced spiral or oblique diaphyseal fracture of the second to fifth metacarpals with definition of diaphysis as described by AO 2018 (AO/OTA as 77.2-5.2A) (Meinberg et al., 2018).
- Fracture line length at least twice the diameter of the bone at the level of the fracture.
- Fractures with at least 2 mm of radiological displacement and/or malrotation of injured finger compared to uninjured side regardless of fracture displacement.
You may not qualify if:
- The patient IS NOT expected to have difficulty adhering to the study protocol (e.g., due to insufficient language proficiency, dementia, substance abuse, or other reasons).
- The patient DOES NOT have an open fracture (Gustilo-Anderson grade \> I) or a pathological fracture.
- The patient DOES NOT have an ipsilateral fracture of the upper extremity, polytrauma, or generalized joint dysfunction (e.g., rheumatoid arthritis).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Uppsala Universitycollaborator
- Umeå Universitycollaborator
- University of Oslocollaborator
- Tampere Universitycollaborator
- Københavns Universitetcollaborator
- Göteborg Universitycollaborator
- Linkoeping Universitycollaborator
- Region Stockholmcollaborator
- Östersund Hospitalcollaborator
Study Sites (1)
Karolinska Institutet, Danderyd's hospital
Stockholm, Stockholm County, 18288, Sweden
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD
Study Record Dates
First Submitted
December 15, 2025
First Posted
January 22, 2026
Study Start
March 23, 2026
Primary Completion (Estimated)
March 15, 2030
Study Completion (Estimated)
March 15, 2031
Last Updated
March 24, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Data on group level will be made available upon reasonable request.